$22 Billion is the total value of Point72 Asset Management, L.P.'s 989 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IGT | INTERNATIONAL GAME TECHNOLOGcall | $16,887,000 | -11.2% | 1,300,000 | 0.0% | 0.08% | -17.2% | |
| ARRY | ARRAY BIOPHARMA INCcall | $12,190,000 | +71.1% | 500,000 | 0.0% | 0.06% | +57.1% | |
| OUT | OUTFRONT MEDIA INCcall | $7,020,000 | +29.1% | 300,000 | 0.0% | 0.03% | +18.5% | |
| PCG | PG&E CORPcall | $5,340,000 | -25.1% | 300,000 | 0.0% | 0.02% | -31.4% | |
| GPRE | GREEN PLAINS INCcall | $5,004,000 | +27.2% | 300,000 | 0.0% | 0.02% | +21.1% | |
| SRRA | SIERRA ONCOLOGY INC | $2,918,000 | +29.6% | 1,706,229 | 0.0% | 0.01% | +18.2% | |
| SNP | CHINA PETE & CHEM CORP | $2,506,000 | +12.6% | 31,521 | 0.0% | 0.01% | 0.0% | |
| MLND | MILLENDO THERAPEUTICS INC | $1,135,000 | +88.5% | 75,670 | 0.0% | 0.01% | +66.7% | |
| PIRS | PIERIS PHARMACEUTICALS INC | $1,145,000 | +26.0% | 341,667 | 0.0% | 0.01% | +25.0% | |
| ACA | ARCOSA INC | $851,000 | +10.4% | 27,861 | 0.0% | 0.00% | 0.0% | |
| ONTX | ONCONOVA THERAPEUTICS INC | $798,000 | +56.5% | 241,850 | 0.0% | 0.00% | +100.0% | |
| MGEN | MIRAGEN THERAPEUTICS INC | $320,000 | -8.0% | 114,691 | 0.0% | 0.00% | -50.0% | |
| PRVB | PROVENTION BIO INC | $131,000 | +31.0% | 56,751 | 0.0% | 0.00% | – | |
| GREK | GLOBAL X FDSmsci greece etf | $241,000 | +16.4% | 30,000 | 0.0% | 0.00% | 0.0% | |
| SSYS | STRATASYS LTD | $78,000 | +32.2% | 3,255 | 0.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TR | 41 | Q2 2024 | 8.3% |
| CME GROUP INC | 41 | Q2 2024 | 0.3% |
| AMAZON COM INC | 39 | Q2 2024 | 3.2% |
| META PLATFORMS INC | 38 | Q1 2024 | 2.2% |
| XENON PHARMACEUTICALS INC | 38 | Q2 2024 | 0.4% |
| CSX CORP | 37 | Q2 2024 | 1.3% |
| BUNGE LIMITED | 37 | Q2 2023 | 1.5% |
| VULCAN MATLS CO | 37 | Q2 2024 | 0.9% |
| BERRY PLASTICS GROUP INC | 37 | Q1 2024 | 0.8% |
| GENERAL MTRS CO | 36 | Q2 2024 | 1.1% |
View Point72 Asset Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Sphere Entertainment Co. | June 24, 2024 | 1,560,170 | 5.5% |
| UroGen Pharma Ltd. | June 24, 2024 | 2,569,826 | 6.2% |
| Olema Pharmaceuticals, Inc. | June 14, 2024 | 3,225,250 | 5.7% |
| MARAVAI LIFESCIENCES HOLDINGS, INC. | June 10, 2024 | 4,481,050 | 3.4% |
| Rapid7, Inc. | May 21, 2024 | 3,121,415 | 5.0% |
| Corvus Pharmaceuticals, Inc. | May 09, 2024 | 17,050,384 | 9.9% |
| Avid Bioservices, Inc. | April 26, 2024 | 3,226,006 | 5.1% |
| SUTRO BIOPHARMA, INC. | April 05, 2024 | 5,791,505 | 7.7% |
| Fox Corp | March 26, 2024 | 12,046,118 | 5.0% |
| LENZ Therapeutics, Inc. | March 25, 2024 | 864,942 | 3.4% |
View Point72 Asset Management, L.P.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-09-16 |
| SC 13G | 2024-09-05 |
| N-PX | 2024-09-03 |
| 13F-HR/A | 2024-08-19 |
| 13F-HR | 2024-08-14 |
| SC 13G | 2024-07-02 |
| SC 13G | 2024-06-24 |
| SC 13G | 2024-06-24 |
| SC 13G | 2024-06-14 |
| SC 13G | 2024-06-10 |
View Point72 Asset Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.